HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
ETC-1001
Description
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
No brand information found.
